Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 3546 entries
View as:

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

Phase: N/A Priority: Normal
NCT ID: NCT00698061 Org: User:
Start: 11/30/99 End: 05/31/01 Due: 05/31/02

Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT00380211 Org: User:
Start: 09/30/06 End: 11/30/06 Due: 11/30/07

Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00757770 Org: User:
Start: 08/31/03 End: 01/31/04 Due: 01/31/05

The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT03072719 Org: User:
Start: 03/01/12 End: 06/12/12 Due: 06/12/13

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02164513 Org: User:
Start: 06/30/14 End: 07/17/17 Due: 07/17/18

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Phase: N/A Priority: Normal
NCT ID: NCT06897527 Org: User:
Start: 04/17/25 End: 06/01/26 Due: 06/01/27

Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04095286 Org: User:
Start: 09/30/19 End: 12/17/19 Due: 12/17/20

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00449670 Org: User:
Start: 03/24/07 End: 06/10/08 Due: 06/10/09

Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT02731833 Org: User:
Start: 04/01/16 End: 05/20/16 Due: 05/20/17

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00085813 Org: User:
Start: 12/31/03 End: 10/31/05 Due: 10/31/06

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04472897 Org: User:
Start: 10/30/20 End: 11/06/24 Due: 11/06/25

Phase 2b Study of GSK4532990 in Adults With NASH

Phase: N/A Priority: Normal
NCT ID: NCT05583344 Org: User:
Start: 01/02/23 End: 04/05/27 Due: 04/05/28

Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study

Phase: N/A Priority: Normal
NCT ID: NCT01418937 Org: User:
Start: 05/29/12 End: 01/09/15 Due: 01/09/16

Relative Bioavailability Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00924911 Org: User:
Start: 04/27/09 End: 07/09/09 Due: 07/09/10

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00244712 Org: User:
Start: 07/31/05 End: 04/30/08 Due: 04/30/09

Treatment Of Symptomatic Asthma In Children

Phase: N/A Priority: Normal
NCT ID: NCT00197106 Org: User:
Start: 06/30/05 End: 10/31/08 Due: 10/31/09

A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.

Phase: N/A Priority: Normal
NCT ID: NCT00730847 Org: User:
Start: 09/17/08 End: 01/16/12 Due: 01/16/13

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

Phase: N/A Priority: Normal
NCT ID: NCT00322335 Org: User:
Start: 05/31/06 End: 09/30/10 Due: 09/30/11

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

Phase: N/A Priority: Normal
NCT ID: NCT00445510 Org: User:
Start: 06/30/06 End: - Due: -

Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02586493 Org: User:
Start: 10/01/15 End: 03/15/16 Due: 03/15/17

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Phase: N/A Priority: Normal
NCT ID: NCT01751165 Org: User:
Start: 03/12/13 End: 04/08/15 Due: 04/08/16

Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01362283 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)

Phase: N/A Priority: Normal
NCT ID: NCT04965636 Org: User:
Start: 07/11/22 End: 10/09/25 Due: 10/09/26

Indirect Comparison Topotecan Cervical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01345279 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

Phase: N/A Priority: Normal
NCT ID: NCT00372255 Org: User:
Start: 11/17/05 End: 03/28/06 Due: 03/28/07